Cresco Labs (CRLBF) Exchange Rate Effect (2020 - 2024)
Cresco Labs (CRLBF) reported Exchange Rate Effect of $9000.0 for Q4 2024, up 140.91% on a YoY basis from $3735.8 in Q1 2024, and up 136.0% quarter-over-quarter from -$25000.0 in Q3 2024.
Cresco Labs (CRLBF) Exchange Rate Effect (2020 - 2024) Analysis & Trends
Cresco Labs has reported Exchange Rate Effect for 5 years, with the latest figure at $9000.0 in Q4 2024.
- For the quarter ending Q4 2024, Exchange Rate Effect rose 140.91% year-over-year to $9000.0; the trailing twelve-month figure through Dec 2024 stood at -$31000.0 (down 179.49% YoY), and the FY2024 full-year result was -$39000.0, up 37.1% from the prior year.
- Exchange Rate Effect for Q4 2024 stood at $9000.0, up from -$25000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $134000.0 in Q4 2021, with the low at -$1.6 million in Q3 2020.
- Historically, Exchange Rate Effect has averaged -$162461.5 across 5 years, with a median of -$22000.0 in 2023.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect surged 170.16% — and 2024, when it slumped 457.14%.
- Cresco Labs' Exchange Rate Effect stood at -$191000.0 in 2020, then surged by 170.16% to $134000.0 in 2021, then plunged by 67.16% to $44000.0 in 2022, then slumped by 150.0% to -$22000.0 in 2023, then jumped by 140.91% to $9000.0 in 2024.
- The last three Exchange Rate Effect figures came in at $9000.0 (Q4 2024), -$25000.0 (Q3 2024), and -$22000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 74,000.00 |
| Sep 30, 2021 | 74,000.00 |
| Jun 30, 2021 | -270,000.00 |
| Jun 30, 2021 | -270,000.00 |
| Mar 31, 2021 | -169,000.00 |
| Mar 31, 2021 | -169,000.00 |